VRTX - VERTEX PHARMACEUTICALS INC / MA
477.89
3.620 0.757%
Share volume: 989,412
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$474.27
3.62
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-02-2024 | 11-05-2024 | 02-13-2025 | 05-06-2025 | 08-05-2025 | 11-04-2025 | 02-13-2026 | |
| Total revenue | 2.691 B | 2.646 B | 2.772 B | 2.912 B | 2.770 B | 2.965 B | 3.076 B | 3.190 B | |
| Cost of revenue | 342.600 M | 371.900 M | 392.600 M | 423.400 M | 363.000 M | 407.500 M | 414.800 M | 466.000 M | |
| Gross profit | 2.348 B | 2.274 B | 2.379 B | 2.489 B | 2.407 B | 2.557 B | 2.662 B | 2.724 B | |
| -3.16% | 4.64% | 4.59% | -3.27% | 6.23% | 4.08% | 2.34% | |||
| Operating expenses | 1.132 B | 1.339 B | 1.263 B | 1.464 B | 1.396 B | 1.405 B | 1.477 B | 1.517 B | |
| Selling general and admin | 342.700 M | 372.200 M | 371.800 M | 377.600 M | 396.400 M | 424.600 M | 445.100 M | 487.000 M | |
| Research and development | 789.100 M | 966.600 M | 890.900 M | 1.086 B | 999.500 M | 980.600 M | 1.032 B | 1.030 B | |
| Total expenses | 1.474 B | 1.711 B | 1.263 B | 1.463 B | 1.777 B | 1.406 B | 1.475 B | 1.518 B | |
| 16.03% | -26.17% | 15.80% | 21.50% | -20.88% | 4.93% | 2.89% | |||
| Operating income | 1.216 B | 934.900 M | 1.116 B | 1.026 B | 630.100 M | 1.151 B | 1.186 B | 1.206 B | |
| Ebit | 1.216 B | 934.900 M | 1.099 B | 1.011 B | 612.500 M | 1.164 B | 1.176 B | 1.212 B | |
| Pretax income | 1.279 B | -3.391 B | 1.224 B | 1.137 B | 730.400 M | 1.283 B | 1.299 B | 1.331 B | |
| -365.12% | -136.10% | -7.16% | -35.73% | 75.66% | 1.23% | 2.48% | |||
| Income tax | 179.500 M | 202.400 M | 178.700 M | 223.500 M | 84.100 M | 250.100 M | 215.900 M | 139.900 M | |
| Net income basic | 1.100 B | -3.594 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -426.81% | 100.00% | ||||||||
| Net income | 1.100 B | -3.594 B | 1.045 B | 913.000 M | 646.300 M | 1.033 B | 1.083 B | 1.191 B | |
| -426.81% | 129.09% | -12.67% | -29.21% | 59.82% | 4.84% | 9.99% |